GlassScriptPhysician profile
Eunice Dugan
NPI 1659869162
$4,300.64
in general payments reported to CMS, 2019-2025
7 companies · $1,607 in 2025
The $1,607 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,693 · 2025: $1,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,971 · Travel and Lodging: $1,060 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,971.38 |
| Travel and Lodging | $1,060.42 |
| Education | $268.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,092.97 | 2024-2025 | Optis, Dragonfly Opstar, Diamondback Coronary |
| Edwards Lifesciences Corporation | $616.19 | 2024-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $346.00 | 2024-2025 | Corevalve Evolut R, Symplicity G3 |
| Abiomed | $149.74 | 2025 | |
| Boston Scientific Corporation | $47.96 | 2024 | Avvigo Guidance System, Rotapro |
| Philips North America LLC | $32.00 | 2025 | Labosys |
| Terumo Medical Corporation | $15.78 | 2025 | Angio-Seal, Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunice Dugan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.